Truyền dung dịch vasopressin liều thấp trong giai đoạn tiền phẫu để phòng ngừa và quản lý hội chứng hạ huyết áp do giãn mạch ở bệnh nhân phẫu thuật bắc cầu động mạch vành - Một nghiên cứu ngẫu nhiên mù đôi
Tóm tắt
Từ khóa
Tài liệu tham khảo
Carrel T, Englberger L, Mohacsi P, Neidhart P, Schmidli J: Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance. J Card Surg. 2000, 15: 347-353. 10.1111/j.1540-8191.2000.tb00470.x.
Sun X, Zhang L, Hill PC, Lowery R, Lee AT, Molyneaux RE, Corso PJ, Boyce SW: Is incidence of postoperative vasoplegic syndrome different between off-pump and on-pump coronary artery bypass grafting surgery?. Eur J Cardiothorac Surg. 2008, 34: 820-825. 10.1016/j.ejcts.2008.07.012.
Noto A, Lentini S, Versaci A, Giardina M, Risitano DC, Messina R, David A: A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery. Interact CardioVascular and Thoracic Surgery. 2009, 9: 588-92. 10.1510/icvts.2009.209890.
Laffey JG, Boylan JF, Cheng DC: The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology. 2002, 97: 215-52. 10.1097/00000542-200207000-00030.
Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med. 2001, 345: 588-595. 10.1056/NEJMra002709.
Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH: A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med. 2004, 350: 105-113. 10.1056/NEJMoa025431.
Gomes WJ, Carvalho AC, Palma JH, Goncalves I, Buffolo E: Vasoplegic syndrome: a new dilemma. J Thorac Cardiovasc Surg. 1994, 107: 942-3.
Gomes WJ, Carvalho AC, Palma JH, Teles CA, Branco JN, Silas MG, Buffolo E: Vasoplegic syndrome after open heart surgery. J Cardiovasc Surg (Torino). 1998, 39: 619-23.
Levin RL, Degrange MA, Bruno GF, Del Mazo CD, Taborda DJ, Griotti JJ, Boullon FJ: Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg. 2004, 77: 496-9. 10.1016/S0003-4975(03)01510-8.
Shanmugam G: Vasoplegic syndrome-the role of methylene blue. Eur J Cardio-thoracic Surg. 2005, 28: 705-10. 10.1016/j.ejcts.2005.07.011.
Argenziano M, Chen J, Choundhri A, Cullinane S, Garfein E, Weinberg AD, Smith CR, Rose EA, Landry DW, Oz MC: Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg. 1998, 116: 973-80. 10.1016/S0022-5223(98)70049-2.
Luckner G, Duenser M, Jochberger S, Mayr VD, Wenzel V, Ulmer H, Schmid S, Knotzer H, Pajk W, Hasibeder W, Mayr AJ, Friesenecker B: Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med. 2005, 33: 2659-2666. 10.1097/01.CCM.0000186749.34028.40.
Duenser MW, Wenzel V, Mayr AJ, Hasibeder WR: Management of vasodilatory shock: Defining the role of arginine vasopressin. Drugs. 2003, 63: 237-256. 10.2165/00003495-200363030-00001.
Duenser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, Friesenecker B, Hasibeder WR: Arginine vasopressin in advanced vasodilatory shock: A prospective, randomized, controlled study. Circulation. 2003, 107: 2313-2319. 10.1161/01.CIR.0000066692.71008.BB.
Morales D, Garrido M, Madigan J, Helman D, Faber J, Williams M, Landry D, Oz M: A double-blind randomized trial: Prophylactic Vasopressin Reduces Hypotension After Cardiopulmonary Bypass. Ann Thorac Surg. 2003, 75: 926-30. 10.1016/S0003-4975(02)04408-9.
Morales D, Gregg D, Helman D, Williams MR, Naka Y, Landry DW, Oz MC: Arginine vasopressin in the treatment of fifty patients with postcardiotomy vasodilatory shock. Ann Thorac Surg. 2000, 69: 102-6. 10.1016/S0003-4975(99)01197-2.
Raja S, Dreyfus G: Vasoplegic syndrome after Off-pump coronary artery bypass surgery. Tex Heart Inst J. 2004, 31: 421-24.
Mekontso-Dessap A, Houel R, Soustelle C, Kirsch M, Thebert D, Loisance DY: Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg. 2001, 71: 1428-32. 10.1016/S0003-4975(01)02486-9.
Tuman KJ, McCarthy RJ, O'Connor CJ, Holm WE, Ivankovich AD: Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass. Anesth Analg. 1995, 80: 473-9. 10.1097/00000539-199503000-00007.
Mets B, Michler RE, Delphin ED, Oz MC, Landry DW: Refractory vasodilation after cardiopulmonary bypass for heart transplantation in recipients on combined amiodarone and angiotensin-converting enzyme inhibitor therapy: a role for vasopressin administration. J Cardiothorac Vasc Anesth. 1998, 12: 326-9. 10.1016/S1053-0770(98)90017-9.
Argengiano M, Choudhri A, Oz M, Rose E, Smith C, Landry D: A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation. 1997, 96: 286-290.
Carrel T, Englberger L, Mohacsi P, Neidhart P, Schmidli J: Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance. J Card Surg. 2000, 15: 347-53. 10.1111/j.1540-8191.2000.tb00470.x.
Patel B, Chittock D, Russell J, Walley K: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology. 2002, 96: 576-82. 10.1097/00000542-200203000-00011.
Suojaranta-Ylinen R, Vento R, Patila T, Kukkonen S: Vasopressin, when added to norepinephrine, was not associated with increased predicted mortality after cardiac surgery. Scand J Surg. 2007, 96: 314-18.
Morales DL, Landry DW, Oz MC: Therapy for vasodilatory shock: Arginine vasopressin. Semin Anesth Periop Med. 2000, 19: 98-107. 10.1053/sa.2000.6789.
Masetti P, Murphy SF, Kouchoukos NT: Vasopressin therapy for vasoplegic syndrome following cardiopulmonary bypass. J Card Surg. 2002, 17: 485-9. 10.1046/j.1540-8191.2002.01002.x.
Malay MB, Ashton RC, Landry DW, Townsend RN: Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma. 1999, 47: 699-705. 10.1097/00005373-199910000-00014.
Albright T, Zimmerman M, Selzman C: Vasopressin in the cardiac surgery intensive care unit. Am J Crit Care. 2002, 11: 326-332.
Mutlu G, Factor P: Role of vasopressin in the management of septic shock. Intensive Care Med. 2004, 30: 1276-91.
Torqersen C, Duenser M, Wenzel V, Jochberger S, Mayr V, Schmittinger CA, Lorenz I, Schmid S, Westphal M, Grander W, Luckner G: Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial. Intensive Care Med. 2009, 36: 57-65. 10.1007/s00134-009-1630-1.
Argenziano M, Chen JM, Cullinane S, Choudhri AF, Rose EA, Smith CR, Edwards NM, Landry DW, Oz MC: Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation. J Heart Lung Transplant. 1999, 18: 814-817. 10.1016/S1053-2498(99)00038-8.
Tayama E, Ueda T, Shojima T, Akasu K, Oda T, Fukunaga S, Akashi H, Aoyagi S: Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension. Interact CardioVasc Thorac Surg. 2007, 6: 715-719. 10.1510/icvts.2007.159624.
Leone M, Albanese J, Delmas A, Chaabane W, Garnier F, Martin C: Terlipressin in catecholamine-resistant septic shock patients. SHOCK. 2004, 22: 314-319. 10.1097/01.shk.0000136097.42048.bd.
Novella S, Martínez C, Pagán R, Hernández R, García-Sacristán A, González-Pinto A, González-Santos J, Benedito S: Plasma levels and vascular effects of vasopressin in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg. 2007, 32: 69-76. 10.1016/j.ejcts.2007.03.047.
Delmas A, Leone M, Rousseau S, Albanese J, Martin C: Clinical review: Vasopressin and terlipressin in septic shock patients. Critical Care. 2005, 9: 212-222. 10.1186/cc2945.
Wenzel V, Lindner K: Employing vasopressin during cardiopulmonary resuscitation and vasodilatory shock as a lifesaving vasopressor. Cardiovascular Research. 2001, 51: 529-541. 10.1016/S0008-6363(01)00262-0.
Wenzel V, Lindner K, Prengel A, Maier C, Voelckel W, Lurie KG, Strohmenger HU: Vasopressin improves vital organ blood flow after prolonged cardiac arrest with postcounter-shock pulseless activity in pigs. Crit Care Med. 1999, 27: 486-92. 10.1097/00003246-199903000-00022.
Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA: The effects of vasopressin on hemodynamics and renal function in severe septic shock: A case series. Intensive Care Med. 2001, 27: 1416-21. 10.1007/s001340101014.
Bragadottir G, Redfors B, Nygren A, Sellgren J, Ricksten SE: Low-dose vasopressin increases glomerular filtration rate, but impairs renal oxygenation in post-cardiac surgery patients. Acta Anesthesiol Scand. 2009, 53: 1052-59. 10.1111/j.1399-6576.2009.02037.x.
Duenser MW, Fries DR, Schobersberger W, Ulmer H, Wenzel V, Friesenecker B, Hasibeder WR, Mayr AJ: Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with severe multiorgan dysfunction syndrome?. Anesth Analg. 2004, 99: 201-206. 10.1213/01.ANE.0000118105.85933.8A.
Treschan T, Peters J: The vasopressin system: Physiology and clinical strategies. Anesthesiology. 2006, 105: 599-612. 10.1097/00000542-200609000-00026.